G. Horváth

795 total citations
38 papers, 442 citations indexed

About

G. Horváth is a scholar working on Genetics, Reproductive Medicine and Molecular Biology. According to data from OpenAlex, G. Horváth has authored 38 papers receiving a total of 442 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Genetics, 9 papers in Reproductive Medicine and 7 papers in Molecular Biology. Recurrent topics in G. Horváth's work include Estrogen and related hormone effects (15 papers), Endometrial and Cervical Cancer Treatments (7 papers) and Ovarian cancer diagnosis and treatment (7 papers). G. Horváth is often cited by papers focused on Estrogen and related hormone effects (15 papers), Endometrial and Cervical Cancer Treatments (7 papers) and Ovarian cancer diagnosis and treatment (7 papers). G. Horváth collaborates with scholars based in Sweden, Hungary and Finland. G. Horváth's co-authors include Henrik Andersson, Begoña Manuel‐y‐Keenoy, Jan Vertommen, I. De Leeuw, Mats Hahlin, U Stendahl, Tom Bäck, Marcel A. K. Jansen, Sture Lindegren and R Caubergs and has published in prestigious journals such as SHILAP Revista de lepidopterología, European Journal of Cancer and European Journal of Clinical Nutrition.

In The Last Decade

G. Horváth

35 papers receiving 422 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. Horváth Sweden 12 126 84 80 80 78 38 442
Yuichiro Miyamoto Japan 16 285 2.3× 73 0.9× 116 1.4× 186 2.3× 120 1.5× 50 800
S. Djahansouzi Germany 9 117 0.9× 45 0.5× 114 1.4× 17 0.2× 16 0.2× 16 377
Helene Hildegard Heidegger Germany 14 220 1.7× 113 1.3× 150 1.9× 28 0.3× 31 0.4× 45 510
Yong‐Tark Jeon South Korea 9 225 1.8× 138 1.6× 109 1.4× 53 0.7× 47 0.6× 16 431
Marina Ivanovic United States 9 178 1.4× 45 0.5× 90 1.1× 57 0.7× 26 0.3× 18 627
Geertruida N. Jonges Netherlands 10 146 1.2× 98 1.2× 196 2.5× 88 1.1× 29 0.4× 20 515
Jing Peng China 11 209 1.7× 115 1.4× 192 2.4× 31 0.4× 19 0.2× 24 534
Jie Meng China 15 258 2.0× 158 1.9× 124 1.6× 11 0.1× 28 0.4× 52 561

Countries citing papers authored by G. Horváth

Since Specialization
Citations

This map shows the geographic impact of G. Horváth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Horváth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Horváth more than expected).

Fields of papers citing papers by G. Horváth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Horváth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Horváth. The network helps show where G. Horváth may publish in the future.

Co-authorship network of co-authors of G. Horváth

This figure shows the co-authorship network connecting the top 25 collaborators of G. Horváth. A scholar is included among the top collaborators of G. Horváth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Horváth. G. Horváth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Österberg, Lovisa, Kristina Levan, Karolina Partheen, et al.. (2009). High-Resolution Genomic Profiling of Carboplatin Resistance in Early-Stage Epithelial Ovarian Carcinoma. Cytogenetic and Genome Research. 125(1). 8–18. 15 indexed citations
2.
Brännström, Mats, et al.. (2007). Population-based cohort follow-up study of all patients operated for borderline ovarian tumor in western Sweden during an 11-year period. International Journal of Gynecological Cancer. 18(3). 453–459. 32 indexed citations
3.
Horváth, G., Ludger A. Wessjohann, Joseph Bigirimana, et al.. (2006). Accumulation of tocopherols and tocotrienols during seed development of grape (Vitis vinifera L. cv. Albert Lavallée). Plant Physiology and Biochemistry. 44(11-12). 724–731. 62 indexed citations
4.
Puistola, Ulla, et al.. (2006). Matrix metalloproteinases-2 and -9 in cervical cancer: different roles in tumor progression. International Journal of Gynecological Cancer. 16(3). 1297–1302. 40 indexed citations
5.
Levan, Kristina, Karolina Partheen, Lovisa Österberg, Khalil Helou, & G. Horváth. (2006). Chromosomal alterations in 98 endometrioid adenocarcinomas analyzed with comparative genomic hybridization. Cytogenetic and Genome Research. 115(1). 16–22. 20 indexed citations
6.
Pérez‐Cruz, Fernando, et al.. (2003). Extension of the nu-SVM range for classification. Acta Haematologica. 83(4). 179–196. 13 indexed citations
7.
Horváth, G., et al.. (2003). Oxidative stress status in patients with diabetes mellitus: relationship to diet. European Journal of Clinical Nutrition. 57(8). 999–1008. 68 indexed citations
8.
Horváth, G., et al.. (2000). Exon deletions and variants of human estrogen receptor mRNA in endometrial hyperplasia and adenocarcinoma. International Journal of Gynecological Cancer. 10(2). 128–136. 23 indexed citations
9.
Nanda, Shivani, et al.. (1999). Captopril-Induced Toxic Epidermal Necrolysis and Agranulocytosis Successfully Treated With Granulocyte Colony-Stimulating Factor. Southern Medical Journal. 92(9). 918–920. 10 indexed citations
10.
Karlsson, Linnéa, Ulla Delle, & G. Horváth. (1997). Short- and long-term oestradiol treatment inhibits growth and alters expression ofp21WAF1/cip1 in an endometrial adenocarcinoma cell line lacking functional p53. European Journal of Cancer. 33(13). 2252–2257. 3 indexed citations
11.
Andersson, Henrik, et al.. (1997). Taxol given weekly in advanced previously treated ovarian carcinomas - a pilot study. International Journal of Gynecological Cancer. 7(4). 262–266. 10 indexed citations
12.
Karlsson, Linnéa, et al.. (1996). Characterisation of a human endometrial adenocarcinoma established in vivo and in vitro.. PubMed. 10(4). 421–8. 2 indexed citations
13.
Alm, P., et al.. (1995). Identification of small areas of solid growth has a strong prognostic impact in differentiated endometrial carcinomas. A histopathologic and morphometric study. International Journal of Gynecological Cancer. 5(2). 87–93. 6 indexed citations
14.
15.
Bebők, Zsuzsa, et al.. (1993). [Creation of monoclonal antibodies against tumor necrosis factor-alpha (TNF-alpha) and transforming growth factor alpha (TFG-alpha), their definition and possible use].. PubMed. 134(24). 1303–7. 2 indexed citations
16.
Horváth, G., et al.. (1992). Characterization of an estradiol-independent but estradiol-responsive growth phenotype in a human endometrial adenocarcinoma heterotransplanted into nude mice. International Journal of Gynecological Cancer. 2(2). 101–106. 1 indexed citations
17.
Horváth, G., et al.. (1990). A phase II study of toremifene in carcinoma corporis uteri. Preliminary communication. Journal of Steroid Biochemistry. 36(3). 241–241. 1 indexed citations
18.
Horváth, G., J. E. Johnsson, Claes G. Tropé, et al.. (1990). Influence of "nuclear" estrogen receptor content on prognosis of early stage carcinoma of the uterine body. A short-time follow-up.. PubMed. 37(1). 43–6. 1 indexed citations
19.
Horváth, G., et al.. (1989). Estrogen receptor activation in relation to previous estrogen treatment in carcinoma corporis uteri heterotransplanted into nude mice.. PubMed. 3(2). 93–7. 4 indexed citations
20.
Thorvinger, B., et al.. (1989). Staging in Local Endometrial Carcinoma. Acta Radiologica. 30(5). 525–529. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuichiro Miyamoto Breakdown of academic impact, for papers by S. Djahansouzi Breakdown of academic impact, for papers by Helene Hildegard Heidegger Breakdown of academic impact, for papers by Yong‐Tark Jeon Breakdown of academic impact, for papers by Marina Ivanovic Breakdown of academic impact, for papers by Geertruida N. Jonges Breakdown of academic impact, for papers by Jing Peng Breakdown of academic impact, for papers by Jie Meng
Rankless by CCL
2026